ROLE OF SIMPLIFIED ADMISSION CRITERIA FOR PREDICTING SEVERE COMPLICATIONS OF GALL STONE PANCREATITIS

Authors

  • Azhar Shah
  • Faheem ul Haq
  • Anayat Ullah
  • Riaz Ur Rehman

Abstract

Background: Gallstone Pancreatitis (GP) is not an uncommon disease in our country and is associatedwith large number of morbidity and mortality especially if severe complications develop. Differentcriteria have been developed to predict the complications of GP. Simple admission criteria are betterpredictors of severe complications of GP than an APACHE II score of 5 or greater, a modified Imrie(Glasgow) score of 3 or greater, and a Biliary Ranson score of 3 or greater. The purpose of this studywas to determine the role of simplified admission criteria in predicting severe complications ofGallstone Pancreatitis. Methods: This was a descriptive study conducted in Surgical ‘A’ Unit, KhyberTeaching Hospital Peshawar between July 16th 2007 to November 30th 2008. Total 52 patients (42women and 10 men, aged range from 18 to 76 years, with mean age, 39 years) who presented to ourunit with gallstone pancreatitis were included in the study through technique of non-probabilityconvenient sampling. The main outcome measures were major local and systemic complicationsrequiring intensive care unit care, and death. Physiologicalfactors and laboratory data were collected onadmission and recorded daily. Results: Seven patients (14%) had severe complications with mortalityof 2%. On univariate analysis, a white blood cell count of 14500/dL or more (p=0.03), a serum glucoselevel of or more ≥150 mg/dL (8.3 mmol/L) (p<0.001), anAPACHE II score of 5 or greater (p=0.008), amodified Imrie score of 3 or greater (p<0.001), and a biliary Ranson score of 3 or greater (p=0.03) werestatistically associated with the development of severe complications. On multivariate analysis, only aserum glucose level of ≥150 mg/dL or more (8.3 mmol/L) was predictive of adverse events (p<0.001).Conclusions: Glucose level (≥150 mg/dL) is the best single admission predictor of severecomplications of Gallstone Pancreatitis and is superior to an APACHE II score of 5 or greater, amodified Imrie score of 3 or greater, anda biliary Ranson score of 3 or greater.Keywords: Gallstones pancreatitis, admission criteria, complications

References

Steinberg W, Tenner S. Acute pancreatitis. N Engl J Med

;330:1198–210.

Ranson JHC, Rifkind KM, Roses DF, Fink SD, Eng K, Spencer

FC. Prognostic signs and the role of operative management in

acute pancreatitis. Surg Gynecol Obstet 1974;139:69–81.

Ranson JHC. Etiologic and prognostic factors in human acute

pancreatitis: a review. Am J Gastroenterol 1982;77:633–8.

Imrie CW, Benjamin IS, Ferguson JC, McKay AJ, Mackenzie I,

O’Neill J, Blumgart LH. A single-centre double-blind trial of

Trasylol therapy in primary acute pancreatitis. Br J Surg

;65:337–41.

Osborne DH, Imrie CW, Carter DC. Biliary surgery in the same

admission for gallstone-associated acute pancreatitis. Br J Surg

;68:758–61.

Blamey SL, Imrie CW, O'Neill J, Gilmour WH, Carter DC.

Prognostic factors in acute pancreatitis. Gut 1984;25:1340–6.

Arnell TD, de Virgilio C, Chang L, Bongard F, Stabile BE.

Admission factors can predict the need for ICU monitoring in

gallstone pancreatitis. Am Surg 1996;62:815–9.

de Virgilio C, Verbin C, Chang L, Linder S, Stabile B, Klein S.

Gallstone pancreatitis: the role of preoperative endoscopic

retrograde cholangiopancreatography. Arch Surg

;129:909–13.

Wilson C, Heath DI, Imrie CW. Prediction of outcome in acute

pancreatitis: a comparative study of APACHE II, clinical

assessment and multiple factor scoring systems. Br J Surg

;77:1260–4.

Neoptolemos JP, Ogunbiyi O, Wilson PG, Carr-Locke DL.

Etiology, pathogenesis, natural history, and treatment of biliary

acute pancreatitis. In: Beger HG, Warshaw AL, Buchler MW,

(eds.) The Pancreas. London, England: Blackwell Scientific

Publishers Ltd; 1998.p. 521–47.

Leese T, Shaw D. Comparison of three Glasgow multifactor

prognostic scoring systems in acute pancreatitis. Br J Surg

;75:460–2.

Corfield AP, Cooper MJ, Williamson RC, Mayer AD, McMahon

MJ, Dickson AP, Shearer MG, Imirie CW. Prediction of severity

in acute pancreatitis: prospective comparison of three prognostic

indices. Lancet 1985;2(8452):403–7.

Larvin M, McMahon M. APACHE II score for assessment and

monitoring of acute pancreatitis. Lancet 1989;2:201–5.

McMahon MJ, Playforth MJ, Pickford IR. A comparative study

of methods for the prediction of severity of attacks of acute

pancreatitis. Br J Surg 1980;67:22–5.

Tran DD, Cuesta MA. Evaluation of severity in patients with

acute pancreatitis. Am J Gastroenterol 1992;87:604–8.

Fan ST, Lai ECS, Mok FPT, Lo C, Zheng S, Wong J. Prediction

of the severity of acute pancreatitis. Am J Surg 1993;166:262–9.

Fan ST, Choi TK, Lai ECS, Wong J. Prediction of severity of

acute pancreatitis: an alternative approach. Gut 1989;30:1591–5.

Seligson U, Cho J, Nygen A, Reichard P. Is glucose intolerance

after pancreatitis related to pancreatic tissue damage? Acta Med

Scand 1983;213:119–22.

Solomon SS, Duckwork WC, Jallepalli P, Bobal MA, Iyer R.

The glucose intolerance of acute pancreatitis; hormonal response

to arginine. Diabetes 1980;29:22–6.

Donowitz M, Hendler R, Spiro HM, Binder HJ, Felig P.

Glucagon secretion in acute and chronic pancreatitis. Ann Intern

Med 1975;83:778–81.

Malecka-Panas E, Rogozinski R, Torzecka W, Krysiak G,

Kozlowska A. Diagnosis of diabetes mellitus and disorders of

glucose tolerance in patients after acute pancreatitis. Pol Tyg Lek.

;45:370–2.

Olszewski S, Kinalska I, Dlugosz J, Gabryelewicz A. The

glucose tolerance, insulin response and pancreatic exocrine

function in patients after acute pancreatitis. Endokrinologie

;71:183–91.

Published

2010-09-01

Most read articles by the same author(s)